{
    "eid": "2-s2.0-84955202712",
    "title": "Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug na\u00efve first episode psychosis",
    "cover-date": "2015-03-19",
    "subject-areas": [
        {
            "$": "Psychiatry and Mental Health",
            "@code": "2738"
        },
        {
            "$": "Biological Psychiatry",
            "@code": "2803"
        }
    ],
    "keywords": [
        "Cytokines",
        "Drug na\u00efve",
        "First episode psychosis (FEP)",
        "Oxidative stress",
        "Paraoxonase (PON1)",
        "Schizophrenia"
    ],
    "authors": [
        "Francis Fregonesi Brinholi"
    ],
    "citedby-count": 32,
    "ref-count": 37,
    "ref-list": [
        "A depression rating scale for schizophrenics",
        "Paraoxonase 1 (PON1) reduces macrophage inflammatory responses",
        "Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia",
        "Molecular Evidence for Increased Expression of Genes Related to Immune and Chaperone Function in the Prefrontal Cortex in Schizophrenia",
        "Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development",
        "Oxidative stress and psoriasis: The effect of antitumour necrosis factor-\u03b1 inhibitor treatment",
        "Paraoxonase-1 status in Crohn's disease and ulcerative colitis",
        "Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder",
        "Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia",
        "Interleukin-6 upregulates paraoxonase 1 gene expression via an AKT/NF-\u03baB-dependent pathway",
        "Lipid peroxidation in patients with schizophrenia",
        "An atherogenic lipid profile with low serum paraoxonase-1 activity during nematode infection in rats",
        "Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response",
        "Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia",
        "A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics",
        "The positive and negative syndrome scale (PANSS) for schizophrenia",
        "PEP-1-PON1 protein regulates inflammatory response in raw 264.7 macrophages and ameliorates inflammation in a TPA-Induced animal model",
        "Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1\u03b2 and tumor necrosis factor-\u03b1, but is upregulated by interleukin-6",
        "PON1 is a longevity gene: Results of a meta-analysis",
        "Paraoxonase 1 activity and lipid profile in schizophrenic patients",
        "Paraoxonase and coronary heart disease",
        "Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells",
        "Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression",
        "Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques",
        "Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects",
        "Cytokines and schizophrenia: Microglia hypothesis of schizophrenia",
        "Oxidative & nitrosative stress in depression: Why so much stress?",
        "Effects of risperidone on cytokine profile in drug-na\u00efve first-episode psychosis",
        "Effects of depression on the cytokine profile in drug na\u00efve first-episode psychosis",
        "Determination of paraoxonase 1 status without the use of toxic organophosphate substrates.",
        "Tissue distribution and expression of paraoxonases and chemokines in mouse: The ubiquitous and joint localisation suggest a systemic and coordinated role",
        "The Th2-hypothesis of schizophrenia: A strategy to identify a subgroup of schizophrenia caused by immune mechanisms",
        "The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence",
        "Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine",
        "Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis",
        "Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures",
        "Anthocyanin supplementation improves HDL-Associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Londrina",
            "affilname": "Universidade Estadual de Londrina",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Sao Paulo",
            "affilname": "Universidade Federal de S\u00e3o Paulo",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Sao Paulo",
            "affilname": "Faculdade de Ciencias Medicas da Santa Casa de Sao Paulo",
            "affiliation-country": "Brazil"
        }
    ],
    "funding": [
        "Funda\u00e7\u00e3o ABADS",
        "Funda\u00e7\u00e3o Safra",
        "Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo",
        "Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo",
        "Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior",
        "Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior",
        "Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico"
    ]
}